EUVIMEDEUVIMED entdecken
Crossref

Impact of Radiation Therapy on Malignant Rhabdoid Tumor of the Kidney: A National Cancer Database Analysis

David M Gannon iD, Gustavo Sosa, Harold N Lovvorn, Daniel J Benedetti iD, Eric T Shinohara, Austin N Kirschner, Leo Y Luo iD

Pediatric Blood & Cancer · 2026-05 · 73 (5)

DOI: 10.1002/1545-5017.70219 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Blood & Cancer, online erschienen am 15.03.2026. Verfasst von David M Gannon und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, USA. Hauptthemen laut MEDLINE: Rhabdoid Tumor, Kidney Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Malignant rhabdoid tumor of the kidney (MRTK) is a rare and aggressive tumor, primarily affecting infants and young children. Intensive multimodal treatment is standard, entailing chemotherapy, surgery, and radiation therapy (RT). Although previous studies have demonstrated the importance of chemotherapy and surgery, the impact of RT on patient outcomes is unclear.

Methods

Patients diagnosed with MRTK from 2004 to 2019 were analyzed from the National Cancer Database. Patients who did not receive surgery or chemotherapy or died within 30 days after surgery were excluded. Kaplan–Meier survival analyses were conducted to evaluate overall survival (OS) of the entire cohort, stratified by age, metastatic disease, and RT utilization. Log‐rank tests were used to compare survival distributions.

Results

The cohort included 103 patients. Median age was

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rhabdoid TumorKidney NeoplasmsHumansFemaleInfantDatabases, FactualChild, PreschoolMaleSurvival RateChildAdolescentInfant, NewbornFollow-Up StudiesPrognosisRetrospective Studies

Stichwörter der Autor:innen

National Cancer Databasemalignant rhabdoid tumorradiation therapy

Autor:innen und Institutionen

  • Department of Radiation Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Department of Pediatric Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Department of Pediatrics, Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

ORCID-Profile: David M Gannon, Daniel J Benedetti, Leo Y Luo

Förderung

  • NCI NIH HHS

Zitieren

APA

Gannon, D. M., Sosa, G., Lovvorn, H. N., Benedetti, D. J., Shinohara, E. T., Kirschner, A. N., & Luo, L. Y. (2026). Impact of Radiation Therapy on Malignant Rhabdoid Tumor of the Kidney: A National Cancer Database Analysis. Pediatric Blood & Cancer, 73(5). https://doi.org/10.1002/1545-5017.70219

Vancouver

Gannon DM, Sosa G, Lovvorn HN, Benedetti DJ, Shinohara ET, Kirschner AN, et al. Impact of Radiation Therapy on Malignant Rhabdoid Tumor of the Kidney: A National Cancer Database Analysis. Pediatric Blood & Cancer. 2026;73(5). doi:10.1002/1545-5017.70219

BibTeX
@article{Gannon2026,
  author = {Gannon, David M and Sosa, Gustavo and Lovvorn, Harold N and Benedetti, Daniel J and Shinohara, Eric T and Kirschner, Austin N and Luo, Leo Y},
  title = {Impact of Radiation Therapy on Malignant Rhabdoid Tumor of the Kidney: A National Cancer Database Analysis},
  journal = {Pediatric Blood & Cancer},
  year = {2026},
  volume = {73},
  number = {5},
  doi = {10.1002/1545-5017.70219}
}
Kostenlos starten →